(b) Requirements.--A person or organization that acquires
and maintains the overdose reversal medication naloxone for use
in accordance with this section shall:
(1) ensure that an individual expected to administer
naloxone receive training in accordance with subsection (c);
(2) maintain the supply of naloxone in a safe and
accessible location and ensure that the supply is replaced
before the expiration date provided by the manufacturer;
(3) provide instruction requiring the individual
administering the naloxone to utilize available means to
immediately contact emergency medical services; and
(4) ensure that any appropriate data or information is
made available to emergency medical services personnel or
other health care providers as requested.
(c) Training.--For purposes of this section, an individual
expected to administer naloxone shall complete training in
recognizing opioid-related overdoses and administering naloxone
consistent with Department of Health guidelines and in
consultation with the Department of Drug and Alcohol Programs.
(d) Obstruction of emergency medical services personnel.--
Nothing in this section shall relieve an individual who
administers naloxone from civil damages when the individual
obstructs or interferes with care and treatment being provided
by emergency medical services personnel or a health
professional.
(e) Exception.--An individual who lacks the training in
accordance with subsection (c) and who has access to naloxone
and in good faith administers naloxone in an emergency as any
ordinary, reasonably prudent individual would do under the same
or similar circumstances shall receive immunity from civil
20170HB1246PN1490 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30